Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Y Chiang

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Pharmacological and Toxicological Methods|March 6, 2018
The evaluation of endpoint variability and implications for study statistical power and sample size in conscious instrumented dogsAlan Y Chiang, Brian D Guth, Michael K Pugsley, et al.
Puerto Rico Health Sciences Journal|September 24, 2014
Characteristics of Latinas in Puerto Rico and the US mainland receiving teriparatide in the DANCE observational studyValerie A Ruff, Agaph Acosta, Oscar Soto-Raices, et al.
Bone|November 26, 2013
Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatmentYanfei L Ma, Qing Q Zeng, Alan Y Chiang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 9, 2014
A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral densityRobert R Recker, Charles T Benson, Toshio Matsumoto, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 25, 2015
The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral DensityChristopher P Recknor, Robert R Recker, Charles T Benson, et al.
Journal of Pharmacological and Toxicological Methods|April 7, 2015
The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortiumBrian D Guth, Alan Y Chiang, Jennifer Doyle, et al.
Journal of Pharmacological and Toxicological Methods|January 10, 2017
An evaluation of the utility of LVdP/dt<sub>40</sub>, QA interval, LVdP/dt<sub>min</sub> and Tau as indicators of drug-induced changes in contractility and lusitropy in dogsMichael K Pugsley, Brian Guth, Alan Y Chiang, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 2, 2010
Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imagingSteven K Engle, Philip F Solter, Kelly M Credille, et al.
Toxicologic Pathology|June 25, 2009
Qualification of cardiac troponin I concentration in mouse serum using isoproterenol and implementation in pharmacology studies to accelerate drug developmentSteven K Engle, William H Jordan, Michael L Pritt, et al.
Plos One|January 13, 2017
Non-Lethal Endotoxin Injection: A Rat Model of HypercoagulabilityMarjory B Brooks, James R Turk, Abraham Guerrero, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Pharmacological and Toxicological Methods|March 6, 2018
The evaluation of endpoint variability and implications for study statistical power and sample size in conscious instrumented dogsAlan Y Chiang, Brian D Guth, Michael K Pugsley, et al.
Puerto Rico Health Sciences Journal|September 24, 2014
Characteristics of Latinas in Puerto Rico and the US mainland receiving teriparatide in the DANCE observational studyValerie A Ruff, Agaph Acosta, Oscar Soto-Raices, et al.
Bone|November 26, 2013
Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatmentYanfei L Ma, Qing Q Zeng, Alan Y Chiang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 9, 2014
A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral densityRobert R Recker, Charles T Benson, Toshio Matsumoto, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 25, 2015
The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral DensityChristopher P Recknor, Robert R Recker, Charles T Benson, et al.
Journal of Pharmacological and Toxicological Methods|April 7, 2015
The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortiumBrian D Guth, Alan Y Chiang, Jennifer Doyle, et al.
Journal of Pharmacological and Toxicological Methods|January 10, 2017
An evaluation of the utility of LVdP/dt<sub>40</sub>, QA interval, LVdP/dt<sub>min</sub> and Tau as indicators of drug-induced changes in contractility and lusitropy in dogsMichael K Pugsley, Brian Guth, Alan Y Chiang, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 2, 2010
Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imagingSteven K Engle, Philip F Solter, Kelly M Credille, et al.
Toxicologic Pathology|June 25, 2009
Qualification of cardiac troponin I concentration in mouse serum using isoproterenol and implementation in pharmacology studies to accelerate drug developmentSteven K Engle, William H Jordan, Michael L Pritt, et al.
Plos One|January 13, 2017
Non-Lethal Endotoxin Injection: A Rat Model of HypercoagulabilityMarjory B Brooks, James R Turk, Abraham Guerrero, et al.
Pageof 4